AB067. New drug development for the use of PARP1-E2F1 transcriptional inhibitors in the treatment of glioblastoma

  1. Arce, V.M.
  2. Iglesias, P.
  3. Moreira, D.
  4. Porres-Ventin, L.
  5. Gonzalez-Rendo, L.
  6. Zumalave, J.A.
  7. Costoya, J.A.
Journal:
Chinese clinical oncology

ISSN: 2304-3873

Year of publication: 2024

Volume: 13

Pages: AB067

Type: Article

DOI: 10.21037/CCO-24-AB067 GOOGLE SCHOLAR lock_openOpen access editor